Format

Send to

Choose Destination
Korean J Gastroenterol. 2017 Jan 25;69(1):1-28. doi: 10.4166/kjg.2017.69.1.1.

[Second Korean Guideline for the Management of Ulcerative Colitis].

[Article in Korean]

Author information

1
Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
2
Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea.
3
Department of Internal Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.
4
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.
5
Division of Gastroenterology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
6
Division of Gastroenterology, Department of Medicine, Soonchunhyang University College of Medicine, Cheonan, Korea.
7
Division of Colon and Rectal Surgery, Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.
8
Center for Preventive Medicine and Public Health, Seoul National University Bundang Hospital, Seongnam, Korea.
9
Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
10
Department of Internal Medicine, Hanyang University College of Medicine, Guri, Korea.

Abstract

Ulcerative colitis (UC) is a chronic inflammatory bowel disorder characterized by a relapsing and remitting course. The direct and indirect costs of the treatment of UC are high, and the quality of life of patients is reduced, especially during exacerbation of the disease. The incidence and prevalence of UC in Korea are still lower than those of Western countries, but have been rapidly increasing during the past decades. Various medical and surgical therapies, including biologics, are currently used for the management of UC. However, many challenging issues exist, which sometimes lead to differences in practice between clinicians. Therefore, the Inflammatory Bowel Disease Study Group of the Korean Association for the Study of Intestinal Diseases established the first Korean guideline for the management of UC in 2012. This is an update of the first guideline. It was generally made by the adaptation of several foreign guidelines as was the first edition, and encompasses treatment of active colitis, maintenance of remission, and indication of surgery for UC. The specific recommendations are presented with the quality of evidence and classification of recommendations.

KEYWORDS:

Colitis, ulcerative; Guideline; Inflammatory bowel disease; Management

PMID:
28135789
DOI:
10.4166/kjg.2017.69.1.1
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for The Korean Society of Gastroenterology
Loading ...
Support Center